Zhengye Biotechnology Holding Limited’s (NASDAQ:ZYBT) Lock-Up Period To End on July 7th

Zhengye Biotechnology’s (NASDAQ:ZYBT) lock-up period is set to end on Monday, July 7th. Zhengye Biotechnology had issued 1,500,000 shares in its IPO on January 7th. The total size of the offering was $6,000,000 based on an initial share price of $4.00. After the expiration of the company’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.

Zhengye Biotechnology Stock Performance

Zhengye Biotechnology stock opened at $6.17 on Wednesday. Zhengye Biotechnology has a 12 month low of $3.50 and a 12 month high of $14.30. The company has a 50 day moving average price of $8.62.

Zhengye Biotechnology Company Profile

Zhengye Biotechnology Holding Limited is a veterinary vaccine manufacturer which encompasses research, development, manufacturing and sales of veterinary vaccines, with a focus on livestock vaccine principally in China. Zhengye Biotechnology Holding Limited is based in Jilin, China.